Skip to content
  • Home
  • 書包: 0 items (滿)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
高級檢索
  • Correction: GPRC5D as a novel...
  • 引用
  • 發送短信
  • 打印
  • 導出紀錄
    • 導出到 RefWorks
    • 導出到 EndNoteWeb
    • 導出到 EndNote
  • 添加到書包 從書包裡刪除
  • Permanent link

Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review

書目詳細資料
發表在:Blood Cancer Journal
Main Authors: Paula Rodriguez-Otero, Niels W. C. J. van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Philippe Moreau, Nizar Bahlis, Ajai Chari
格式: Article
語言:英语
出版: Nature Publishing Group 2024-03-01
在線閱讀:https://doi.org/10.1038/s41408-024-01018-6
  • 持有資料
  • 實物特徵
  • 相似書籍
  • 職員瀏覽

因特網

https://doi.org/10.1038/s41408-024-01018-6

相似書籍

  • GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
    由: Paula Rodriguez-Otero, et al.
    出版: (2024-02-01)
  • S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    由: Cyrille Touzeau, et al.
    出版: (2023-08-01)
  • P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MONUMENTAL-1
    由: Leo Rasche, et al.
    出版: (2023-08-01)
  • Characterization and Management of Cytokine Release Syndrome From the MonumenTAL‐1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma
    由: Niels W. C. J. van deDonk, et al.
    出版: (2025-10-01)
  • 689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2
    由: Lien Vandenberk, et al.
    出版: (2023-11-01)

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題